The FTC’s Second Interim Report on PBMs Signals Reform Will Remain in Focus Throughout 2025 and Highlights Ongoing Scrutiny of PBM business Practices
On January 14, 2025, the FTC released its Second Interim Report, titled Specialty Generic Drugs: A Growing Profit Center for Vertically Integrated Pharmacy Benefit Managers.